1. Home
  2. OPK vs DRTS Comparison

OPK vs DRTS Comparison

Compare OPK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.37

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$13.14

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPK
DRTS
Founded
2006
2015
Country
United States
Israel
Employees
N/A
121
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
OPK
DRTS
Price
$1.37
$13.14
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$1.60
$8.67
AVG Volume (30 Days)
4.6M
553.0K
Earning Date
04-28-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$606,879,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
$699.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$3.01
52 Week High
$1.73
$14.11

Technical Indicators

Market Signals
Indicator
OPK
DRTS
Relative Strength Index (RSI) 49.40 57.08
Support Level $1.25 $11.24
Resistance Level $1.41 $14.00
Average True Range (ATR) 0.09 0.80
MACD 0.01 -0.02
Stochastic Oscillator 27.43 69.05

Price Performance

Historical Comparison
OPK
DRTS

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: